Treatment of cutaneous tumors with topical 5% imiquimod cream
INTRODUCTION: There are various approaches to the treatment of cutaneous tumors; one of them is treatment with imiquimod, a synthetic toll-like receptor agonist with a low molecular weight that offers a topical, noninvasive, and non-surgical therapeutic option. The main objective of our study was to...
Main Authors: | Sabrina Sisto Alessi, Jose Antonio Sanches, Walmar Roncalli de Oliveira, Maria Cristina Messina, Eugenio Raul de Almeida Pimentel, Cyro Festa Neto |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculdade de Medicina / USP
2009-01-01
|
Series: | Clinics |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322009001000005 |
Similar Items
-
Facial basal cell carcinoma treated with topical 5% imiquimod cream with dermoscopic evaluation
by: Archana Singal, et al.
Published: (2016-01-01) -
Melanoma "in situ" tratado con Imiquimod Melanoma in situ treated with Imiquimod
by: RE Achenbach, et al.
Published: (2012-01-01) -
Successful treatment of giant basal cell carcinoma with topical imiquimod 5% cream with long term follow-up
by: M Chun-Guang, et al.
Published: (2014-01-01) -
Imiquimod 5% cream in topical treatment of facial basal cell carcinoma
by: Grubor Svetlana D., et al.
Published: (2015-01-01) -
Topical Imiquimod Treatment of Lentigo Maligna
by: F. Ventura, et al.
Published: (2009-10-01)